首页|期刊导航|中草药|三叶苷-磷脂复合物/壳聚糖纳米粒的制备、口服药动学及对急性肝损伤保护作用评价

三叶苷-磷脂复合物/壳聚糖纳米粒的制备、口服药动学及对急性肝损伤保护作用评价OA

Trifolin-phospholipids complex/chitosan nanoparticles:Preparation,oral pharmacokinetics in vivo and evaluation of protective effect on acute liver injury

中文摘要英文摘要

目的 制备三叶苷-磷脂复合物/壳聚糖纳米粒(trifolin-phospholipids complex/chitosan nanoparticles,Tri-PC/CS-NPs),考察Tri-PC/CS-NPs体内药动学行为及对急性肝损伤的保护作用.方法 采用溶剂挥发法制备三叶苷-磷脂复合物(trifolin-phospholipids complex,Tri-PC).采用单因素实验结合 Box-Behnken 设计-效应面法(Box-Behnken design-response surface methodology,BBD-RSM)优化 Tri-PC/CS-NPs 处方工艺.采用透射电子显微镜(transmission electron microscope,TEM)观察 Tri-PC/CS-NPs 形貌,X 射线粉末衍射法(X-ray powder diffraction,XRPD)分析 Tri-PC/CS-NPs 晶型.比较三叶苷、Tri-PC、Tri-PC/CS-NPs的饱和溶解度、油水分配系数及其在模拟胃肠液中的释药行为.SD大鼠分别ig给予三叶苷、Tri-PC、Tri-PC/CS-NPs,测定血药浓度,计算主要药动学参数.建立急性肝损伤大鼠模型,比较三叶苷、Tri-PC、Tri-PC/CS-NPs对急性肝损伤大鼠的保护作用.结果 Tri-PC/CS-NPs最佳处方:水相体积为20.50mL,Tri-PC与壳聚糖质量比为4.15∶1,泊洛沙姆188质量分数为0.10%.Tri-PC/CS-NPs的包封率、载药量、粒径及ζ电位分别为(84.80±1.21)%、(15.56±0.10)%、(197.74±5.58)nm 和(32.69±1.14)mV.Tri-PC/CS-NPs 外貌为类球形.三叶苷在 Tri-PC 和 Tri-PC/CS-NPs 中均以无定形形态存在.Tri-PC和Tri-PC/CS-NPs极显著性提高了三叶苷的饱和溶解度及油水分配系数(P<0.01).Tri-PC和Tri-PC/CS-NPs 在 18 h 内累积释放率分别为 56.68%和88.45%.Tri-PC/CS-NPs的释药行为符合Weibull模型.以三叶苷为参考,Tri-PC和Tri-PC/CS-NPs相对生物利用度分别增加至2.41倍和5.36倍.Tri-PC和Tri-PC/CS-NPs有效增强了三叶苷对急性肝损伤大鼠的保护作用,且Tri-PC/CS-NPs效果优于Tri-PC.结论 Tri-PC/CS-NPs改变了三叶苷的体内药动学行为,有效促进了三叶苷的体内吸收,并增强了三叶苷对急性肝损伤的保护作用.

Objective To prepare trifolin-phospholipids complex/chitosan nanoparticles(Tri-PC/CS-NPs),and investigate its in vivo pharmacokinetic behavior and protective effect on acute liver injury.Methods Trifolin-phospholipids complex(Tri-PC)was prepared by solvent evaporation method.Single factor experiments combined Box-Behnken design-response surface methodology(BBD-RSM)were used to optimize the prescriptions of Tri-PC/CS-NPs.Transmission electron microscope(TEM)was employed to observe microscopic appearance of Tri-PC/CS-NPs,X-ray powder diffraction(XRPD)was used to analyze crystal form of Tri-PC/CS-NPs.Saturated solubility,oil/water partition coefficient and drug release behavior in simulated gastrointestinal fluids of trifolin,Tri-PC and Tri-PC/CS-NPs were compared.SD rats were administered intragastrically with trifolin,Tri-PC and Tri-PC/CS-NPs,respectively.Blood drug concentration was determined,and the main pharmacokinetic parameters were calculated.The model of acute liver injury was established,and the protective effect of trifolin,Tri-PC,Tri-PC/CS-NPs on acute liver injury were compared.Results Optimal formulations of Tri-PC/CS-NPs:the volume of water phase was 20.50 mL,the mass ratio of Tri-PC to chitosan was 4.15∶1,and the mass fraction ofPoloxamer 188 was 0.10%.Envelopment efficiency,drug loading,particle size and ζ potential were(84.80±1.21)%,(15.56±0.10)%,(197.74±5.58)nm and(32.69±1.14)mV,respectively.The appearance of Tri-PC/CS-NPs were spherical.The state of trifolin changed into amorphous form in Tri-PC and Tri-PC/CS-NPs.Tri-PC and Tri-PC/CS-NPs significantly enhanced the saturated solubility and oil/water partition coefficient of trifolin(P<0.01).Cumulative release rate of Tri-PC and Tri-PC/CS-NPs were 56.68%and 88.45%in 18 h,respectively.The drug release process of Tri-PC/CS-NPs conformed to the Weibull model.Compared with trifolin,the relative bioavailability of Tri-PC and Tri-PC/CS-NPs was enhanced to 2.41-fold and 5.36-fold,respectively.Tri-PC and Tri-PC/CS-NPs effectively enhanced the protective effect of trifolin against acute liver injury,and the protective effect of Tri-PC/CS-NPs was superior to that of Tri-PC.Conclusion Tri-PC/CS-NPs changed the pharmacokinetic behavior of trifolin in vivo,effectively promoted the absorption of trifolin,and enhanced the protective effect of trifolin on acute liver injury.

姚杰;姬新颖;王赟华;张体鹏;时艳华;杜娟;尚慧杰;张付利

郑州健康学院,河南郑州 450064郑州健康学院,河南郑州 450064郑州健康学院,河南郑州 450064郑州健康学院,河南郑州 450064郑州健康学院,河南郑州 450064郑州健康学院,河南郑州 450064郑州健康学院,河南郑州 450064郑州健康学院,河南郑州 450064||河南大学,河南开封 475001

医药卫生

三叶苷磷脂复合物壳聚糖纳米粒Box-Behnken设计-效应面法溶解度油水分配系数生物利用度急性肝损伤

trifolinphospholipids complexchitosannanoparticlesBox-Behnken design-response surface methodologysolubilityoil/water partition coefficientbioavailabilityacute liver injury

《中草药》 2026 (17)

6730-6742,13

国家自然科学基金项目(81670088)2025年度郑州市医疗卫生领域科技创新指导计划项目(2025-421)

10.7501/j.issn.0253-2670.2026.17.007

评论